CF
Therapeutic Areas
Kuros Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MagnetOs Granules | Instrumented Posterolateral Fusion (PLF) | Commercial |
| MagnetOs Putty | Lumbar Interbody Fusion (Degenerative Disc Disease) | Commercial |
| MagnetOs Easypack Putty | Transforaminal Lumbar Interbody Fusion (TLIF) | Commercial |
Leadership Team at Kuros Biosciences
PD
Prof. Dr. Joost de Bruijn
Executive Director and President, Innovation & Strategy
DG
Daniel Geiger
Chief Financial Officer
SM
Sjoerd Musters
Chief Operating Officer
JG
John Griffin
Chief Business Officer
DP
Dr. Philippe Saudan
Senior Vice President, Quality, Regulatory and Clinical
GJ
G. Joseph (Joe) Ross
Senior Vice President, Marketing and Business Development
LR
Laura Rosa
Senior Vice President, Global Human Resources
TA
Todd A. Stohler
Vice President, U.S. Sales
DC
Dr. Cesar Silva
Senior Director of Clinical Affairs
DL
Dr. Luuk van Dijk
Director of Medical Affairs